Walleye Trading’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,925
Closed -$790K 5730
2022
Q2
$724K Buy
+2,925
New +$789K ﹤0.01% 2538
2022
Q1
Sell
-3,085
Closed -$1.11M 6139
2021
Q4
$1.11M Buy
+3,085
New +$1.04M ﹤0.01% 2151
2019
Q4
Sell
-10,806
Closed -$2M 4744
2019
Q3
$1.92M Buy
+10,806
New +$2.34M 0.02% 1088
2019
Q1
Sell
-1,298
Closed -$431K 4958
2018
Q4
$422K Sell
1,298
-13,434
-91% -$4.67M ﹤0.01% 2642
2018
Q3
$6.63M Buy
14,732
+14,344
+3,697% +$5.65M 0.03% 499
2018
Q2
$159K Buy
+388
New +$141K ﹤0.01% 3787
2017
Q4
Sell
-1,189
Closed -$200 4738
2017
Q3
$200 Buy
+1,189
New +$180K ﹤0.01% 3232
2017
Q2
Sell
-1,683
Closed -$226K 5099
2017
Q1
$211 Buy
1,683
+368
+28% +$42.7K ﹤0.01% 2919
2016
Q4
$148K Buy
+1,315
New +$152K ﹤0.01% 2993
2015
Q4
Sell
-700
Closed -$65K 5846
2015
Q3
$65K Buy
+700
New +$61.7K ﹤0.01% 3314

Other funds holding ABMD

Walleye Trading's ABMD Position: Q3 2022 in Review

Walleye Trading sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 2,925 shares — an estimated $790K sold.

Walleye Trading first reported a position in ABMD in Q3 2015 and held it in 10 quarters. The position peaked at $6.63M in Q3 2018. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Walleye Trading reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 2,925 Abiomed Inc shares in Q3 2022, an estimated $790K.
  • Walleye Trading first reported a position in Abiomed Inc in Q3 2015 and held it in 10 quarters.
  • Walleye Trading's Abiomed Inc position peaked at $6.63M in Q3 2018.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.